RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1. [electronic resource]
Producer: 20200709Description: 999-1006 p. digitalISSN:- 1090-2104
- Animals
- Brain Neoplasms -- genetics
- Carcinogenesis -- genetics
- Cell Line, Tumor
- Cell Proliferation -- radiation effects
- Chromosomal Proteins, Non-Histone -- antagonists & inhibitors
- DNA (Cytosine-5-)-Methyltransferase 1 -- antagonists & inhibitors
- Decitabine -- pharmacology
- Disease Progression
- Enzyme Inhibitors -- pharmacology
- Gene Expression Regulation, Neoplastic
- Glioblastoma -- genetics
- Guanine Nucleotide Exchange Factors -- antagonists & inhibitors
- Heterografts
- Humans
- Janus Kinase 1 -- genetics
- Mice
- Mice, SCID
- Neoplasm Grading
- Neuroglia -- metabolism
- Prognosis
- RNA, Small Interfering -- genetics
- Radiation Tolerance -- genetics
- STAT Transcription Factors -- genetics
- Signal Transduction
- Survival Analysis
- Transcription, Genetic
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.